Arnaud Bourdin

15.6k total citations · 4 hit papers
288 papers, 6.9k citations indexed

About

Arnaud Bourdin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Arnaud Bourdin has authored 288 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Pulmonary and Respiratory Medicine, 150 papers in Physiology and 48 papers in Surgery. Recurrent topics in Arnaud Bourdin's work include Asthma and respiratory diseases (127 papers), Respiratory and Cough-Related Research (65 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (51 papers). Arnaud Bourdin is often cited by papers focused on Asthma and respiratory diseases (127 papers), Respiratory and Cough-Related Research (65 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (51 papers). Arnaud Bourdin collaborates with scholars based in France, United States and United Kingdom. Arnaud Bourdin's co-authors include Pascal Chanez, Isabelle Vachier, Sandhia Ponnarambil, Andrew Menzies‐Gow, Fabrice Paganin, Peter Barker, Njira Lugogo, Delphine Gras, Marc Humbert and Parameswaran Nair and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Arnaud Bourdin

253 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

2017 716 citations Arnaud Bourdin et al. profile →
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

2021 606 citations Andrew Menzies‐Gow, Arnaud Bourdin et al. profile →
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

2017 441 citations Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal profile →
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

2024 69 citations Arnaud Bourdin, David J. Jackson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Arnaud Bourdin	4.4k	3.6k	1.0k	858	799	288	6.9k
Philip G. Bardin	3.0k 0.7×	3.5k 1.0×	564 0.5×	1.2k 1.4×	886 1.1×	163	6.0k
Matthew Peters	2.8k 0.6×	2.8k 0.8×	580 0.6×	947 1.1×	281 0.4×	217	7.0k
Neil Barnes	6.8k 1.6×	6.8k 1.9×	661 0.6×	1.3k 1.5×	903 1.1×	180	9.4k
Roland Buhl	5.6k 1.3×	5.0k 1.4×	579 0.6×	1000 1.2×	1.5k 1.9×	224	9.6k
James E. Fish	4.4k 1.0×	5.0k 1.4×	448 0.4×	520 0.6×	1.2k 1.5×	109	7.0k
Marco Contoli	2.5k 0.6×	2.5k 0.7×	267 0.3×	1.4k 1.7×	402 0.5×	131	5.1k
Gary M. Hunninghake	3.9k 0.9×	1.9k 0.5×	405 0.4×	701 0.8×	242 0.3×	102	6.3k
Isabelle Tillie‐Leblond	2.3k 0.5×	2.0k 0.6×	355 0.3×	766 0.9×	512 0.6×	121	4.4k
Michael Tamm	4.1k 0.9×	2.1k 0.6×	1.4k 1.4×	1.0k 1.2×	387 0.5×	282	10.5k
Gordon L. Snider	7.0k 1.6×	2.7k 0.7×	1.1k 1.1×	470 0.5×	273 0.3×	207	10.1k

Countries citing papers authored by Arnaud Bourdin

Since Specialization

Citations

This map shows the geographic impact of Arnaud Bourdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Bourdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Bourdin more than expected).

Fields of papers citing papers by Arnaud Bourdin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Bourdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Bourdin. The network helps show where Arnaud Bourdin may publish in the future.

Co-authorship network of co-authors of Arnaud Bourdin

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Bourdin. A scholar is included among the top collaborators of Arnaud Bourdin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Bourdin. Arnaud Bourdin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Canonica, Giorgio Walter, et al.. (2025). Mepolizumab reduced healthcare resource utilization and improved work productivity in patients with severe asthma during the REALITI-A 2-year study. Journal of Asthma. 62(12). 2114–2124.

Bourdin, Arnaud, Anand Shah, Caroline Baxter, et al.. (2025). Dupilumab Improves Lung Function, Asthma Control and Exacerbation Frequency in Allergic Bronchopulmonary Aspergillosis – Results from the Phase 2 LIBERTY ABPA AIRED Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5230–A5230. 2 indexed citations

Jaffuel, Dany, Erika Nogué, François Roubille, et al.. (2025). Association of positive airway pressure adherence with use of antihypertensive drugs in patients with sleep apnoea. ERJ Open Research. 11(4). 81–2025.

Khezrian, Mina, Ekaterina Maslova, Sandeep Patel, et al.. (2025). Predicting Risk of Morbidities Associated with Oral Corticosteroid Prescription for Asthma. PubMed. Volume 16. 95–109. 1 indexed citations

Mallet, Jean‐Pierre, Sarah Skinner, Frédéric Gagnadoux, et al.. (2025). Concerns arising from the calculation of the apnea-hypopnea index during CPAP-telemonitoring of patients with obstructive sleep apnea. Respiratory Research. 26(1). 244–244.

Mallet, Jean‐Pierre, Jean‐Christian Borel, Frédéric Gagnadoux, et al.. (2025). Added value of technician intervention to improve mask management for apneic patients treated with long-term CPAP. Sleep And Breathing. 29(1). 117–117.

Bourdin, Arnaud, Guy Brusselle, Simon Couillard, et al.. (2024). Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 809–823. 24 indexed citations

Bourdin, Arnaud, et al.. (2024). MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab. The Journal of Allergy and Clinical Immunology In Practice. 12(8). 2074–2083.e4. 5 indexed citations

Zysman, M., Camille Taillé, Jésus Gonzalez‐Bermejo, et al.. (2024). What is the true target population for biologics in real-life COPD or asthma-COPD overlap patients?. BMJ Open Respiratory Research. 11(1). e002702–e002702. 2 indexed citations

10.

Bourdin, Arnaud, et al.. (2024). EFFICACY OF BENRALIZUMAB AND MEPOLIZUMAB ON ASTHMA OUTCOMES IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. Annals of Allergy Asthma & Immunology. 133(6). S49–S50. 1 indexed citations

11.

Tran, Trung N., Jennifer Rowell, Jeffrey Shi Kai Chan, et al.. (2024). Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United Kingdom. SHILAP Revista de lepidopterología. 3(2). 100225–100225. 1 indexed citations

12.

Demoly, Pascal, Anne‐Sophie Gamez, Arnaud Bourdin, & Davide Caimmi. (2024). Precision medicine targeting groups of intervention in difficult-to-treat asthma. SPIRE - Sciences Po Institutional REpository. 2. 100013–100013.

13.

Boucly, Athénaïs, Antoine Beurnier, Xavier Jaïs, et al.. (2024). Outcomes and risk assessment in pulmonary veno-occlusive disease. ERJ Open Research. 10(1). 612–2023. 7 indexed citations

14.

Charriot, Jérémy, M. Zysman, Laurent Guilleminault, et al.. (2023). Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”). Biomedicines. 11(3). 740–740. 2 indexed citations

15.

Bideaux, Patrice, et al.. (2023). Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema. International Journal of Molecular Sciences. 24(16). 12609–12609. 3 indexed citations

16.

Gouzi, Farès, Patrice Bideaux, Valérie Scheuermann, et al.. (2023). Diastolic Cardiomyopathy Secondary to Experimentally Induced Exacerbated Emphysema. American Journal of Respiratory Cell and Molecular Biology. 69(2). 230–241. 4 indexed citations

17.

Casale, Thomas B., et al.. (2022). Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies. Therapeutic Advances in Respiratory Disease. 16. 2673686641–2673686641. 10 indexed citations

18.

Suehs, Carey, Khuder Alagha, Arnaud Bourdin, et al.. (2021). Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study. Therapeutic Advances in Respiratory Disease. 15. 2663629063–2663629063. 2 indexed citations

19.

Boucly, Athénaïs, Jason Weatherald, Laurent Savale, et al.. (2021). External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry. European Respiratory Journal. 59(6). 2102419–2102419. 100 indexed citations

20.

Wallaert, B., Jonas Yserbyt, Stavros Anevlavis, et al.. (2017). Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF. Respiration. 93(3). 198–206. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact